WJ Lesterhuis, IJM de Vries, G Schreibelt… - Clinical Cancer …, 2011 - AACR Experimental Design: HLA-A2.1 + melanoma patients scheduled for regional lymph node dissection were vaccinated four times biweekly via intradermal or intranodal injection with 12 × 10 6 to 17 × 10 6 mature DCs loaded with tyrosinase and gp100 peptides together with keyhole ...
RE Donahue, L Tuschong, TR Bauer Jr, YY Yau… - Blood, 2011 - ncbi.nlm.nih.gov Following administration of granulocyte colony-stimulating factor (G-CSF) there is a marked, albeit transient, drop in circulating neutrophils. To determine the role of leukocyte integrins in this disappearance, a dog having canine leukocyte adhesion deficiency (CLAD) or CLAD ...
A Breitenbach - US Patent 20,110,165,247, 2011 - freepatentsonline.com The invention relates to a polymer matrix suitable for the transdermal administration of rotigotine [(−)-5, 6, 7, 8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphtol], containing a matrix for the transdermal administration of rotigotine [(−)-5, 6, 7, 8-tetrahydro-6-[propyl[2-(2-thienyl) ... Cached
[HTML] from jaccjournaloftheacc.comRC Starling, Y Naka, AJ Boyle… - Journal of the …, 2011 - Am Coll Cardio Found Background: After a multicenter pivotal clinical trial conducted from 2005 to 2008, the US Food and Drug Administration approved the HM II LVAD for bridge to transplantation (BTT). A post-approval study was required by the US Food and Drug Administration to determine ... Cited by 2 - Related articles - All 5 versions
[HTML] from duxbury.comLK Gaines… - 2011 - books.google.com Police Administration Third Edition Copyright 2011 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s). Editorial ... Cited by 59 - Related articles - All 8 versions